Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05067634 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

Name: Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures — clinical trial record (NCT05067634)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhasePhase 3

SponsorSK Life Science, Inc.

Started2022-01-10

View on ClinicalTrials.gov ↗

Primary objective: To evaluate the safety and tolerability of cenobamate in pediatric subjects 2-17 years of age with partial-onset (focal) seizures

Amendment history 1 change detected by DataLookout

2026-08-14

Trial sites reduced: 54 → 35 locations

Trial Details

NCT Number	NCT05067634
Lead Sponsor	SK Life Science, Inc.
Conditions	Partial Epilepsy
Enrollment	140 participants
Start Date	2022-01-10
Primary Completion	2026-11 (estimated)
Study Completion	2026-11 (estimated)
Updated on ClinicalTrials.gov	2026-09-09